RxDoctor Payments Data

Timothy Staacke, MD

Interventional Pain Medicine · Kenosha, WINPI 1457335523

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,152 of the $13,243 with a category attached, or 69.1%. It is spread thinly across 25 manufacturers, the largest accounting for just 21.3%.

$13,243in general payments, 2019–2025

Across 168 payments — averaging $78.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$3K
  • Medtronic$2K
  • Nevro Corp.$2K
  • Abbott$1K
  • Boston Scientific$875
  • SPR Therapeutics, Inc$849
  • plus $4K from 19 others

What the payments were for

  • Travel & lodging$4,09231%
  • Food & beverage$9,15269%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,243 in reported general payments places this provider in the 80th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$100,035
Medicare patients
216
Services billed
1,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl37$8,684
SuboxoneBuprenorphine Hcl/Naloxone Hcl14$6,113
Buprenorphine19$4,303
Celecoxib44$2,022
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen179$1,690
Gabapentin100$1,674
Pregabalin47$1,486
Duloxetine Hcl49$874
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$804
Diclofenac Sodium16$566
Amitriptyline Hcl30$469
Baclofen18$284
Methylprednisolone35$221
Tizanidine Hcl17$127
Cyclobenzaprine Hcl20$101

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →